Acorda, Watson sales and marketing update

Watson's Watson Pharma Inc. subsidiary launched in the U.S. an authorized generic of spasticity drug Zanaflex tizanidine from partner Acorda. The wholesale acquisition cost for 150 tablets of 2, 4 and 6 mg is $325, $412 and $619 respectively. Acorda is eligible for royalties on product sales. Details were not disclosed. ...